tiprankstipranks
Matinas BioPharma (MTNB)
:MTNB
US Market

Matinas BioPharma (MTNB) Dividend Date & History

Compare
1,523 Followers
Matinas BioPharma (MTNB) has no upcoming dividends

Other Large Cap Stocks Paying Dividends

Name
Dividend Yield
Smart Score
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Follow
MO
Altria Group
$3.998 (7.36%)
$92.08B
8.31
33.84%
3 Buy
3 Hold
1 Sell
Moderate Buy
T
AT&T
$1.108 (4.24%)
$187.71B
17.53
58.45%
20 Buy
4 Hold
0 Sell
Strong Buy
XRX
Xerox
$1 (12.74%)
$976.34M
-0.73
-57.85%
0 Buy
1 Hold
1 Sell
Moderate Sell
IBM
International Business Machines
$6.676 (2.52%)
$244.79B
41.17
41.95%
7 Buy
6 Hold
1 Sell
Moderate Buy
CVX
Chevron
$6.6 (4.11%)
$285.36B
16.34
1.46%
13 Buy
3 Hold
0 Sell
Strong Buy
EOG
EOG Resources
$3.705 (2.73%)
$76.31B
10.92
18.97%
10 Buy
8 Hold
0 Sell
Moderate Buy
ET
Energy Transfer
$1.282 (6.39%)
$68.42B
15.58
30.22%
8 Buy
1 Hold
0 Sell
Strong Buy
HESM
Hess Midstream Partners
$2.703 (6.39%)
$9.34B
16.57
16.95%
2 Buy
1 Hold
0 Sell
Moderate Buy
ARCC
Ares Capital
$1.916 (8.21%)
$15.71B
9.59
15.76%
7 Buy
1 Hold
0 Sell
Strong Buy

FAQ

Does Matinas BioPharma pay dividends?
No, Matinas BioPharma (MTNB) has not paid a dividend within the past 12 months.
    How much is Matinas BioPharma's dividend?
    Matinas BioPharma (MTNB) does not pay a dividend
    When is Matinas BioPharma ex-dividend date?
    Matinas BioPharma (MTNB) does not pay a dividend.
    When is Matinas BioPharma dividend payment date?
    Matinas BioPharma (MTNB) does not pay a dividend.
    Does Matinas BioPharma have sufficient earnings to cover their dividend?
    The Matinas BioPharma has paid a dividend in the last year and may provide dividends in the near future.
    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis